Physician profile
Peter Sterling Greene
NPI 1407295942
$21,587.61
in general payments reported to CMS, 2019-2025
49 companies · $3,574 in 2025
The $3,574 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,488 · 2020: $80.35 · 2021: $9,241 · 2022: $1,113 · 2023: $1,123 · 2024: $968 · 2025: $3,574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,051 · Travel and Lodging: $1,559 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,051.47 |
| Travel and Lodging | $1,558.79 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,486.75 | 2019-2021 | |
| Boston Scientific Corporation | $1,763.21 | 2019-2025 | General - Therapies, Ams 700, Bulkamid |
| Teleflex LLC | $990.20 | 2022-2025 | Urolift, Barrigel |
| Sumitomo Pharma America, INC. | $451.06 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $433.27 | 2019-2025 | Xtandi, Veozah, Myrbetriq |
| Janssen Biotech, INC. | $414.86 | 2022-2025 | Erleada, Carvykti, Rybrevant |
| Pfizer INC. | $343.22 | 2019-2025 | |
| Coloplast Corp | $336.97 | 2019-2025 | Porges Coloplast |
| Urogen Pharma, INC. | $290.44 | 2021-2025 | Jelmyto |
| Merck Sharp & Dohme LLC | $275.23 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Accord Healthcare, INC. | $215.67 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $205.94 | 2021-2024 | |
| Abbvie INC. | $202.54 | 2022-2025 | |
| Bluewind Medical | $175.62 | 2024-2025 | Revi |
| Dornier Medtech America, INC | $173.94 | 2023 | Dornier Medtech |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $168.59 | 2021-2024 | Xiaflex, Aveed |
| Myovant Sciences INC. | $151.99 | 2021-2022 | |
| Smith+Nephew, INC. | $142.88 | 2022 | |
| Urovant Sciences INC | $140.51 | 2021-2022 | |
| Endo USA, INC. | $137.73 | 2024-2025 | Xiaflex |
| Olympus America INC. | $114.06 | 2019-2024 | Itind System |
| Ferring Pharmaceuticals INC. | $66.89 | 2024-2025 | Adstiladrin |
| Agiliti Surgical, INC. | $59.20 | 2019-2025 | Sonablate Hifu |
| Antares Pharma, INC. | $57.01 | 2021-2024 | Xyosted |
| Seagen INC. | $54.99 | 2025 | |
| Amgen INC. | $54.48 | 2021-2024 | Repatha, Otezla |
| Neotract INC. | $51.90 | 2019 | |
| Telix Pharmaceuticals | $51.86 | 2024 | Illuccix |
| Exact Sciences Corporation | $50.92 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Allergan, INC. | $49.98 | 2019-2021 | |
| Abc Home Medical Supply, INC. | $49.98 | 2025 | |
| Janssen Scientific Affairs, LLC | $47.68 | 2025 | Erleada |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.51 | 2024-2025 | Jardiance |
| 180 Medical, INC. | $28.95 | 2023 | |
| Blue Earth Diagnostics | $26.21 | 2024 | |
| Karl Storz Endoscopy-America | $25.44 | 2025 | Hopkins |
| Hollister Incorporated | $24.59 | 2021 | |
| Procept Biorobotics Corporation | $23.83 | 2023 | Aquabeam Robotic System |
| Sagent Pharmaceuticals | $23.59 | 2024 | Glydo |
| Laborie Medical Technologies Corp. | $21.84 | 2024 | Urgent PC Neuromodulation System |
| Novo Nordisk INC | $21.18 | 2023 | Wegovy |
| Progenics Pharmaceuticals, INC. | $21.06 | 2025 | |
| Alnylam Pharmaceuticals INC. | $20.34 | 2022 | |
| Lilly USA, LLC | $19.81 | 2025 | Zepbound |
| Kowa Pharmaceuticals America, INC. | $19.07 | 2023 | Seglentis |
| Acacia Pharma INC | $17.00 | 2022 | |
| Ambu INC. | $16.04 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $15.84 | 2025 | Bard Urinary Drainage Bag |
| Glaxosmithkline, LLC. | $13.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.